Recursion Pharmaceuticals Inc (RXRX)
9.42
-0.09
(-0.95%)
USD |
NASDAQ |
May 17, 16:00
9.42
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Free Cash Flow (Quarterly): -108.95M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -108.95M |
| December 31, 2023 | -76.49M |
| September 30, 2023 | -73.75M |
| June 30, 2023 | -71.44M |
| March 31, 2023 | -78.66M |
| December 31, 2022 | -52.73M |
| September 30, 2022 | -63.10M |
| June 30, 2022 | -78.10M |
| March 31, 2022 | 73.05M |
| Date | Value |
|---|---|
| December 31, 2021 | -65.62M |
| September 30, 2021 | -42.75M |
| June 30, 2021 | -39.86M |
| March 31, 2021 | -50.17M |
| December 31, 2020 | 3.982M |
| September 30, 2020 | -20.28M |
| June 30, 2020 | -17.33M |
| March 31, 2020 | -18.50M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-108.95M
Minimum
Mar 2024
73.05M
Maximum
Mar 2022
-45.92M
Average
-52.73M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | 83.20M |
| Absci Corp | -17.86M |
| Palatin Technologies Inc | -8.607M |
| Oragenics Inc | -1.102M |
| Actinium Pharmaceuticals Inc | -7.385M |